SCHEMBL3914802

SCHEMBL3914802

COCCc1cncc(Cl)c1CC1CC1N

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19986443 0.70 BDKRB2 (0.31)
SCHEMBL6136930 0.61 PDE4D (0.34)
SCHEMBL12016011 0.61 BDKRB2 (0.41)
SCHEMBL27800366 0.60 PDE4D (0.34)
Hydrochloric Acid SCHEMBL1563435 0.59 PDE4D (0.33)
SCHEMBL1563060 0.59 PDE4D (0.36)
SCHEMBL28211662 0.57 KDM1A (0.44)
SCHEMBL21736851 0.56 PDE4D (0.35)
SCHEMBL844637 0.56 PDE4D (0.33)
SCHEMBL2086898 0.56 PNMT (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090088457-A1 Primary Amines as Renin Inhibitors ACTELION PHARMACEUTICALS, LTD. (CH) 2009-04-02 US disclosed
EP-2029542-A2 PRIMARY AMINES AS RENIN INHIBITORS Actelion Pharmaceuticals Ltd. (CH) 2009-03-04 EP disclosed
WO-2007099509-A2 PRIMARY AMINES AS RENIN INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2007-09-07 WO disclosed